A small clinical trial, reported in The New England Journal of Medicine in June, tested a therapy called zimislecel: stem cell-derived islet cells infused into the liver. In 12 people with severe, long-standing type 1 diabetes, these cells began producing insulin again, improving blood sugar control and preventing dangerous lows
A small clinical trial, reported in The New England Journal of Medicine in June, tested a therapy called zimislecel: stem cell-derived islet cells infused into the liver. In 12 people with severe, long-standing type 1 diabetes, these cells began producing insulin again, improving blood sugar control and preventing dangerous lows A small clinical trial, reported in The New England Journal of Medicine in June, tested a therapy called zimislecel: stem cell-derived islet cells infused into the liver. In 12 people with severe, long-standing type 1 diabetes, these cells began producing insulin again, improving blood sugar control and preventing dangerous lows
